Cellectis
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch Cellectis and buy or sell other stocks, ETFs, and their options commission-free!About CLLS
Cellectis SA operates as a clinical stage biotechnological company, which engages in gene-editing platform to develop cell and gene therapies. The company was founded by David J.
CEOAndré Choulika
CEOAndré Choulika
Employees222
Employees222
HeadquartersParis, Ile-de-France
HeadquartersParis, Ile-de-France
Founded1999
Founded1999
Employees222
Employees222
CLLS Key Statistics
Market cap116.59M
Market cap116.59M
Price-Earnings ratio-2.50
Price-Earnings ratio-2.50
Dividend yield—
Dividend yield—
Average volume52.27K
Average volume52.27K
High today$1.65
High today$1.65
Low today$1.57
Low today$1.57
Open price$1.62
Open price$1.62
Volume37.22K
Volume37.22K
52 Week high$2.43
52 Week high$2.43
52 Week low$1.10
52 Week low$1.10
Analyst ratings
71%
of 7 ratingsBuy
71.4%
Hold
28.6%
Sell
0%